Genmab, a global biotechnology company developing groundbreaking antibody therapies, has launched its “AI Everywhere” initiative, integrating ChatGPT Enterprise across its operations. Utilizing GPT-4o, Genmab is streamlining clinical document creation and translation processes. The company emphasizes security and privacy, conducting thorough evaluations of OpenAI’s compliance. Genmab’s collaboration with OpenAI accelerates innovation in medical treatments and employee productivity.
Source: OpenAI (September 20, 2024)
https://openai.com/index/genmab
Leave a Reply